• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Tamsulin
    / Rafa


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Modified-Release Capsules

    30 X 0.4 mg

    full basket chart 86739 20629

    Related information


    Dosage

    One caplet a day with water after breakfest or the firs meal. To take standing or sitting up.
    See prescribing information for full details.


    Indications

    Functional symptoms of benign prostatic hyperplasia (BPH).


    Contra-Indications

    Hypersensitivity to any component of the product, history of orthostatic hypotension, severe hepatic insufficiency.


    Special Precautions

    Reduction in blood pressure can occur in individual cases during treatment. Use in patients with micturition syncope is not advised. The patient should be examined in order to exclude the presence of other conditions which can cause the same symptoms as benign prostatic hyperplasia. Digital rectal examination, determination of PSA should be performed before treatment and at regular intervals afterwards. Use caution in severely renally impaired patients.


    Side Effects

    Dizziness, abnormal ejaculation, rash, constipation, diarrhea, nausea, vomiting, and, less frequently, headache, exhaustion,orthostatic hypotension, fast or irregular pulse, rhinitis, blurred vision, fainting, dry mouth, edema (rare).


    Drug interactions

    Diclofenac and warfarin may increase tamsulosin elimination rate. Co-administration with other alpha-1-adrenoreceptor antagonists could lead to hypotensive effects.


    Manufacturer
    Bluepharma Industria Farmaceutica
    CLOSE